Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

Share Price is delayed by 15 minutes
Get Live Data
147.50    -1.50 (-1.01%)
Bid:
145.00
Ask:
150.00
Spread: 5.00 (3.448%)
Market Cap: £45.56m
GATC Live PriceLast checked at - London Stock Exchange

Intraday Gattaca Share Chart

Trading Update

17 Feb 2021 07:00

RNS Number : 2974P
Gattaca PLC
17 February 2021
Ā 

17 February 2021

Gattaca plc

Ā 

("Gattaca" or "the Company")

Ā 

Gattaca plc, the specialist Engineering and Technology recruitment solutions business, provides the following trading update for the six months ended 31 January 2021.

Ā 

The Company expects to report Net Fee Income ("NFI") of £21.1m (H1 20 restated: £31.8m), primarily reflecting the market impact of the COVID-19 pandemic over the entire reporting period. The Company expects to report net cash before IFRS16 adjustments of £22.9m (July 2020: £27.3m)¹.

Ā 

Improving activity levels in our core markets continued through Q1 and we were pleased to deliver quarter-on-quarter UK NFI growth of 9% versus Q4. UK NFI in Q2 was 2% higher than Q1, partly impacted by the return of tiered COVID-19 restrictions and extended national lockdowns, coupled with the seasonal impact of the lower number of days worked by contractors over the Christmas period.

Ā 

Given the ongoing effects of the COVID-19 pandemic and the market impact of further national lockdowns, NFI recovery for FY21 is likely to be at a slower rate than previously forecast. However, as a result of appropriate management of the cost base and the underlying improvements in the business we are seeing through the acceleration of our Group-wide Improvement Plan, we currently expect full year underlying PBT to be in line with market expectations.

Ā 

Kevin Freeguard, CEO commented:

Ā 

"Whilst we remain cautious as to the timing of the recovery in our core markets, we have been encouraged by the resilience the business has shown over the first half. I would like to thank our colleagues in the business for their continued hard work and commitment during these challenging times.

Ā 

"Our strong cash position underpins our resilience and, together with the benefits from our ongoing Group-wide Improvement Plan and our core focus on STEM skills which will remain in short supply, positions us well for growth when market conditions inevitably improve. I remain confident of our success over the medium and long term."

Ā 

Gattaca will announce its interim results for the six months ended 31 January 2021 on 31 March 2021.

Ā 

Ā 

Ā 

Ā 

¹VAT deferrals at 31 January 2021 were £10.3m (31 July 2020: £10.3m)

Ā 

Ā 

For further information please contact:

Gattaca plc

+44 (0) 1489 898989

Kevin Freeguard, Chief Executive Officer

Salar Farzad, Chief Financial Officer

Ā 

Ā 

Liberum Capital Limited (Nomad and Broker)

+44 (0) 20 3100 2000

Lauren Kettle

Robert Morton

Euan Brown

Ā 

Ā 

Ā 

Citigate Dewe Rogerson

+44 (0) 20 7638 9571

Jos Bieneman

Nick Hayns

Elizabeth Kittle

Ā 

Ā 

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
TSTQQLFFFLLFBBL
Date   Source Headline
14th May 20267:00 amRNSTrading Update
1st Apr 20267:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
24th Mar 20267:00 amRNSInterim Results
11th Mar 20267:00 amRNSNotice of Results and Investor Presentations
11th Mar 20267:00 amRNSNotice of Results and Investor Presentations
11th Feb 20267:00 amRNSTrading Update
31st Dec 20257:00 amRNSDirector/PDMR dealing
31st Dec 20257:00 amRNSDirector/PDMR dealing
19th Dec 20253:29 pmRNSGrant of Options and Director/PDMR dealing
19th Dec 20253:29 pmRNSGrant of Options and Director/PDMR dealing
16th Dec 202512:19 pmRNSExercise of Options and Director/PDMR Shareholding
11th Dec 20259:05 amRNSResults of Annual General Meeting
10th Nov 20257:00 amRNSAvailability of Report & Accounts and AGM Notice
23rd Oct 20257:00 amRNSFinal results for the year ended 31 July 2025
15th Oct 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
13th Oct 20252:59 pmRNSBlock Listing Six Monthly return
8th Oct 20257:00 amRNSNotice of Results
5th Aug 20257:00 amRNSTrading update and Acquisition
22nd Jul 20257:00 amRNSEBT Share Purchase Programme
21st Jul 20256:22 pmRNSExercise of Options and Director/PDMR Shareholding
2nd Apr 20252:21 pmRNSCORRECTION – Interim Results
2nd Apr 20257:00 amRNSInterim Results
1st Apr 20257:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
13th Feb 20257:00 amRNSTrading Update
27th Jan 20254:51 pmRNSFurther re EBT Share Purchase Programme
11th Dec 20243:59 pmRNSDirector/PDMR Shareholding
11th Dec 20242:25 pmRNSResult of AGM
11th Nov 20242:29 pmRNSAvailability of Report & Accounts and AGM Notice
30th Oct 20247:00 amRNSEBT Share Purchase Programme
24th Oct 20247:00 amRNSFinal results for the year ended 31 July 2024
1st Oct 20247:00 amRNSBlock listing Six Monthly Return
15th Aug 20247:00 amRNSTrading Update for the year ended 31 July 2024
16th Jul 202410:36 amRNSDirector/PDMR Share Purchase
11th Jul 202411:13 amRNSExercise of Options
1st Jul 20247:00 amRNSNominated Adviser and Broker
16th Apr 20247:00 amRNSInterim Results
2nd Apr 20247:00 amRNSBlock listing six monthly return
15th Feb 20247:00 amRNSTrading Update
25th Jan 20247:00 amRNSExercise of Options
6th Dec 20235:07 pmRNSDirector/PDMR Shareholding
6th Dec 20234:51 pmRNSResults of Annual General Meeting
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
20th Nov 20237:00 amRNSTransaction in Own Shares
17th Nov 20237:00 amRNSTransaction in Own Shares
15th Nov 20237:00 amRNSTransaction in Own Shares
14th Nov 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.